Association between EGF +61A/G polymorphism and gastric cancer in Caucasians

doi:10.3748/wjg.v17.i4.488

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2746)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

274

HTML

2341

Tables (1-3)

131

Sum=2746

Jan 28, 2011 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 28, 2011; 17(4): 488-492
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.488

Association between EGF +61A/G polymorphism and gastric cancer in Caucasians

Ana Paula Araújo, Bruno M Costa, Ana L Pinto-Correia, Maria Fragoso, Paula Ferreira, Mário Dinis-Ribeiro, Sandra Costa, Rui M Reis, Rui Medeiros

Ana Paula Araújo, Ana L Pinto-Correia, Paula Ferreira, Rui Medeiros, Molecular Oncology Group, Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal

Bruno M Costa, Sandra Costa, Rui M Reis, Life and Health Sciences Research Institute (ICVS), School of Health Sciences, 4704-553 Braga, Portugal

Maria Fragoso, Oncology Department, Portuguese Institute of Oncology of Porto, 4200-072 Porto, Portugal

Mário Dinis-Ribeiro, Gastroenterology Department, Portuguese Institute of Oncology of Porto, Portugal; and Cintesis/Faculty of Medicine University of Porto, 4200-072 Porto, Portugal

Rui Medeiros, Centro de Estudos em Biomedicina, Health Sciences Faculty-Fernando Pessoa University, 4200-150 Porto, Portugal

Rui Medeiros, Instituto de Ciencias Biomédicas de Abel Salazar, Abel Salazar Institute for the Biomedical Sciences, 4099-003 Porto, Portugal

Author contributions: Araújo AP, Costa BM, Costa S performed the research; Araújo AP and Medeiros R wrote the paper; Fragoso M and Ferreira P identified and diagnosed the patients; Medeiros R and Dinis-Ribeiro M designed, supervised and participated in the editing of the manuscript; all authors read and approved the final manuscript.

Supported by The Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte) and AstraZeneca Foundation

Correspondence to: Rui Medeiros, Professor, Molecular Oncology Group, Portuguese Institute of Oncology of Porto, Edifício Laboratórios-PISO 4, Rua. Dr Ant. Bernardino Almeida, 4200-072 Porto, Portugal. ruimedei@ipoporto.min-saude.pt

Telephone: +351-22-5084000 Fax: + 351-22-5084001

Received: January 26, 2010
Revised: April 30, 2010
Accepted: May 7, 2010
Published online: January 28, 2011

Core Tip